Mainz Biomed NV (MYNZ) Up 8.25% in Premarket Trading

Mainz Biomed NV (MYNZ) is up Monday morning, with the stock climbing 8.25% in pre-market trading to 1.05. MYNZ's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Diagnostics & Research industry, which ranks 104 out of 146 industries, MYNZ ranks higher than 7% of stocks. Mainz Biomed NV has fallen 9.35% over the past month, closing at $1.02 on February 12. During this period of time, the stock fell as low as $0.88 and as high as $1.07. MYNZ has an average analyst recommendation of Buy. The company has an average price target of $3.00.

MYNZ has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on MYNZ!

See Full MYNZ Report

Mainz Biomed NV has a Long-Term Technical rank of 4. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. In the Diagnostics & Research industry which is number 89 by this metric, MYNZ ranks better than 89% of stocks.

Important Dates for Investors in MYNZ:

-Mainz Biomed NV is set to release earnings on 2024-04-08. Over the last 12 months, the company has reported EPS of $-1.92. -We do not have a set dividend date for Mainz Biomed NV at this time. Click Here To Get The Full Report on Mainz Biomed NV (MYNZ)